The US Bankruptcy Court gave an order approving the bidding procedures relating to the sale of substantially all the assets of Sienna Biopharmaceuticals, Inc. on November 13, 2019. To qualify as a qualified bidder, interested parties should submit their bids by December 2, 2019, along with good-faith deposit in the amount of 10% of the proposed purchase price. At the commencement of the auction, the debtor will announce the baseline bid for the applicable assets. The debtor has scheduled an auction on December 5, 2019. At the auction, the subsequent bids would be in increments of amount to be announced at the auction. The stalking horse bidder would be entitled to a break-up fee and expense reimbursement in case of termination of the asset purchase agreement. The sale hearing is scheduled for December 10, 2019.